Pomegranate Health review

Almost every seller in this category describes its pharmacy as a category and stops there — 503A, LegitScript-certified, FDA-registered. Pomegranate prints names, five of them, on the same page as the price: BPI, Empower, Hallandale, Redrock and OptioRx. It also prints something most sellers would rather you found out later, a USP 797 beyond-use-date rule that limits an order to one vial. If you are starting low and planning to stretch a vial, that single sentence changes more than any headline figure on the page. The prices themselves are plain and visible without an intake: compounded semaglutide with B12 and compounded tirzepatide with B6, each priced per month. Two things temper the disclosure. The names are labels, not entities — no legal name, no address — so checking one means starting from a short string. And when those strings are searched against the FDA's live warning-letter index, two of them match companies that hold letters: Empower Clinic Services, LLC dba Empower Pharmacy holds three, and BPI Labs, LLC holds one. Whether the pharmacies filling your prescription are those companies is not something this page lets you establish, which is the honest way to leave it. No milligram is published for either medication, so neither figure is attached to a quantity of drug.

Vs median

$40/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Pomegranate Health dispenses through a Named facility. No bloodwork is required before you start. A clinician review is included in the price.

Almost every seller on this page describes its pharmacy as a category — 503A, LegitScript-certified, FDA-registered — and stops there. Pomegranate prints names, five of them, on the same page as the price, and adds a supply constraint that most sellers would rather a reader discovered later: a USP 797 beyond-use-date rule means one vial per order. For anyone starting low and stretching a vial, that is the sentence on the page that actually changes a plan. Two qualifications matter as much as the disclosure. First, the names are labels, not entities: "BPI", "Empower", "Hallandale", "Redrock" and "OptioRx", with no legal name and no address anywhere on the page, so a reader who wants to check one is starting from a short string. Second, when those strings are searched against the FDA's live warning-letter index, two of them match companies that hold letters — Empower Clinic Services, LLC dba Empower Pharmacy holds three, and BPI Labs, LLC holds one. Whether the pharmacies filling a Pomegranate prescription are those companies is not something the page lets anyone establish. No dose is published for either compounded medication, so neither figure can be attached to a quantity of drug.

The pharmacy names are bare labels with no legal entity or address, so they cannot be checked from the page.

• Two of those labels match compounders that hold FDA warning letters; the page does not let a reader confirm or rule that out.
• No milligram dose is published, so neither price can be attached to a quantity of drug.

Pomegranate Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose